VPS13B and Cowden syndrome 1: Intriguingly, although homozygous or compound heterozygous mutations in VPS13B are identified in most CS patients, only one heterozygous mutation is detected in about 20%–30% of patients, whereas no mutations are identified in 12% of patients, indicating that other genetic mutations and environmental factors are also related to CS pathogenesis [8].